References
- Danish Medicines Agency. Summary of product characteristics for Engerix-B. 2012.
- World Health Organization. WHO-UNICEF estimates of HepB3 coverage. Available at: http://apps.who.int/immunization_monitoring/globalsummary/timeseries/tswucoveragehepb3.html. 2013.
- van Houdt R, Koedijk FD, Bruisten SM, Coul EL, Heijnen ML, Waldhober Q, et al. Hepatitis B vaccination targeted at behavioural risk groups in the Netherlands: does it work? Vaccine 2009;27:3530–5.
- Sundhedsstyrelsen. Vejledning om HIV (human immundefekt virus), hepatitis B og C virus. 2013.
- Petersen CS, Seier KS, Kroon S. Hepatitis B blandt et venerologisk klientel i København. Ugeskrift for Laeger 1984;146:1273–76.
- Das S, Brassington M, Drake SM, Boxall E. Response to hepatitis-B vaccination in healthy homosexual individuals: retrospective case control study. Vaccine 2003; 21:3701–5.
- Mitka M. FDA: Increased HBV reactivation risk with ofatumumab or rituximab. JAMA 2013;310:1664.
- Mereckiene J, Cotter S, Lopalco P, D’Ancona F, Levy-Bruhl D, Giambi C, et al. Hepatitis B immunisation programmes in European Union, Norway and Iceland: where we were in 2009? Vaccine 2010;28:4470–7.
- Mast EE, Weinbaum CM, Fiore AE, Alter MJ, Bell BP, Finelli L, et al. A comprehensive immunization strategy to eliminate transmission of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices (ACIP) Part II: immunization of adults. MMWR Recomm Rep 2006;55(RR-16):1–33; quiz CE1–4.
- Adler MW, French P, McNab A, Smith C, Wellsteed S. The national strategy for sexual health and HIV: implications for genitourinary medicine. Sex Transm Infect 2002;78:83–6.
- Gamagedara N, Weerakoon AP, Zou H, Fehler G, Chen MY, Read TR, et al. Cross-sectional study of hepatitis B immunity in MSM between 2002 and 2012. Sex Transm Infect 2014;90:41–5.
- van Rijckevorsel G, Whelan J, Kretzschmar M, Siedenburg E, Sonder G, Geskus R, et al. Targeted vaccination programme successful in reducing acute hepatitis B in men having sex with men in Amsterdam, the Netherlands. J Hepatol 2013;59:1177–83.
- Hahne S, van Houdt R, Koedijk F, van Ballegooijen M, Cremer J, Bruisten S, et al. Selective hepatitis B virus vaccination has reduced hepatitis B virus transmission in the Netherlands. PLoS One 2013;8:e67866.